Neoral 100mg Capsules
Overview
What is this medicine?
How to Use This Medicine
To ensure you get the most benefit from your medication, follow these guidelines:
Take your medication exactly as directed by your doctor. Read all the information provided with your prescription and follow the instructions carefully.
You can take your medication with or without food, but it's essential to take it the same way each time. Choose to either always take it with food or always take it on an empty stomach.
If you are also taking sirolimus, be sure to take it 4 hours after taking this medication.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel well.
Establish a routine by taking your medication at the same time every day.
Storing and Disposing of Your Medication
To maintain the quality and safety of your medication:
Store it in its original container at room temperature.
Keep it in a dry place, away from the bathroom.
Store all medications in a secure location, out of the reach of children and pets.
What to Do If You Miss a Dose
If you miss a dose, follow these steps:
Take the missed dose as soon as you remember.
However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule.
* Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Take consistently at the same time each day, either with or without food, but always in the same manner.
- Do not switch between different brands of cyclosporine (e.g., Neoral, Gengraf, Sandimmune) without your doctor's explicit instruction, as they are not interchangeable.
- Avoid grapefruit and grapefruit juice, as they can significantly increase cyclosporine levels and lead to toxicity.
- Avoid St. John's Wort, as it can significantly decrease cyclosporine levels and lead to organ rejection.
- Limit sun exposure and use sunscreen/protective clothing due to increased risk of skin cancer.
- Avoid live vaccines while on cyclosporine.
- Maintain good hygiene to reduce infection risk.
- Monitor blood pressure regularly at home if advised by your doctor.
- Report any signs of infection, kidney problems, or other unusual symptoms immediately.
Available Forms & Alternatives
Available Strengths:
Generic Alternatives:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you experience any of the following symptoms, seek medical attention right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood pressure, including:
+ Severe headache
+ Dizziness
+ Fainting
+ Changes in eyesight
Signs of kidney problems, such as:
+ Inability to urinate
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Signs of electrolyte problems, including:
+ Mood changes
+ Confusion
+ Muscle pain, cramps, or spasms
+ Weakness
+ Shakiness
+ Balance problems
+ Abnormal heartbeat
+ Seizures
+ Loss of appetite
+ Severe nausea or vomiting
Unexplained bruising or bleeding
Feeling extremely tired or weak
Abnormal sensations, such as burning, numbness, or tingling
Chest pain or pressure, or a rapid heartbeat
Gum changes
Hearing loss
Shortness of breath
Shakiness
Swelling
Mouth irritation or mouth sores
Liver Problems
This medication can cause liver problems, which can be fatal. If you experience any of the following symptoms, seek medical attention immediately:
Dark urine
Fatigue
Decreased appetite
Nausea or stomach pain
Light-colored stools
Vomiting
Yellow skin or eyes
Progressive Multifocal Leukoencephalopathy (PML)
This medication can cause a rare but serious brain problem called PML, which can lead to disability or death. If you experience any of the following symptoms, seek medical attention immediately:
Confusion
Memory problems
Depression
Changes in behavior
Weakness on one side of the body
Difficulty speaking or thinking
Balance problems
Changes in eyesight
Posterior Reversible Encephalopathy Syndrome (PRES)
This medication can cause a rare but serious brain problem called PRES, which can lead to disability or death. If you experience any of the following symptoms, seek medical attention immediately:
Confusion
Decreased alertness
Changes in eyesight
Loss of eyesight
Seizures
Severe headache
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to report any concerns to your doctor. If you experience any of the following side effects, seek medical attention if they bother you or do not go away:
Headache
Dizziness or drowsiness
Stomach pain or diarrhea
Nausea or vomiting
Gas
Hair growth
Acne
Flushing
Common cold symptoms
Joint pain
Leg cramps
Reporting Side Effects
If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Fever, chills, sore throat, body aches (signs of infection)
- Unusual bruising or bleeding
- Yellowing of skin or eyes (jaundice), dark urine, pale stools (liver problems)
- Swelling in ankles, feet, or hands; decreased urination (kidney problems)
- Severe headache, confusion, seizures, numbness or tingling (neurotoxicity)
- New skin lesions, moles, or changes in existing ones
- Significant increase in blood pressure
- Severe nausea, vomiting, or diarrhea
- Unusual fatigue or weakness
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the symptoms you experienced with the allergy.
Certain health conditions, including:
+ Cancer
+ Kidney problems
+ High blood pressure
Other medications you are taking, such as:
+ Aliskiren
+ Amiloride
+ Bosentan
+ Dabigatran
+ Orlistat
+ Spironolactone
+ Triamterene
If you have psoriasis and are undergoing other treatments, including medications or radiation.
Please note that this is not an exhaustive list of all potential interactions. This medication can interact with numerous other drugs, which may increase the risk of severe, life-threatening, or fatal side effects. Therefore, it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist to ensure safe use. Do not initiate, discontinue, or modify the dosage of any medication without consulting your doctor.
Precautions & Cautions
Before operating a vehicle or engaging in any activity that requires your full attention, wait until you understand how this medication affects you.
If you have diabetes (high blood sugar), it is crucial to closely monitor your blood sugar levels while taking this drug.
If you are using a salt substitute containing potassium, a potassium-sparing diuretic, or any potassium product, consult your doctor to discuss potential interactions.
This medication contains alcohol, so it is important to discuss this with your doctor.
There may be an increased risk of skin cancer associated with this medication. To minimize this risk, limit your exposure to sunlight, sunlamps, and tanning beds, and use protective measures such as sunscreen, clothing, and eyewear. Follow your doctor's recommendations for regular skin checks.
In rare cases, this medication has been linked to severe kidney problems caused by the BK virus, particularly in individuals who have undergone a kidney transplant. This viral infection can lead to kidney loss in transplant patients. If you have concerns, discuss them with your doctor.
Before receiving any vaccinations, consult your doctor, as certain vaccines may not be effective or may increase the risk of infection when taken with this medication.
Maintain good oral hygiene and schedule regular dental check-ups to prevent potential complications.
Avoid consuming grapefruit and grapefruit juice while taking this medication, as they may interact with the drug.
Be aware of the potential for gout attacks and monitor your condition accordingly.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
When administering this medication to children, exercise caution, as the risk of certain side effects may be higher in this population.
This medication may harm an unborn baby if taken during pregnancy. If you become pregnant or suspect you are pregnant while taking this drug, contact your doctor immediately.
If you are breastfeeding, consult your doctor to discuss any potential risks to your baby.
Overdose Information
Overdose Symptoms:
- Nephrotoxicity (acute renal failure)
- Hepatotoxicity
- Neurotoxicity (tremor, seizures, confusion)
- Hypertension
- Gastrointestinal upset
What to Do:
There is no specific antidote. Treatment is supportive and symptomatic. Cyclosporine is not dialyzable. Call 1-800-222-1222 (Poison Control) immediately or seek emergency medical attention.
Drug Interactions
Contraindicated Interactions
- Bosentan (increased cyclosporine levels, hepatotoxicity)
- Aliskiren (increased aliskiren levels, nephrotoxicity)
- Dabigatran (increased dabigatran levels)
- St. John's Wort (decreased cyclosporine levels)
- Live attenuated vaccines (risk of infection)
- Potassium-sparing diuretics (risk of hyperkalemia)
- Grapefruit/grapefruit juice (increased cyclosporine levels)
Major Interactions
- CYP3A4 inhibitors (e.g., ketoconazole, fluconazole, voriconazole, erythromycin, clarithromycin, diltiazem, verapamil, amiodarone, ritonavir, indinavir, nelfinavir, saquinavir) - increased cyclosporine levels
- CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, phenobarbital, nafcillin, octreotide) - decreased cyclosporine levels
- Nephrotoxic agents (e.g., NSAIDs, aminoglycosides, amphotericin B, tacrolimus, sirolimus, methotrexate, trimethoprim/sulfamethoxazole) - increased risk of nephrotoxicity
- Statins (e.g., atorvastatin, simvastatin) - increased statin levels, risk of myopathy/rhabdomyolysis
- Colchicine - increased colchicine levels, toxicity
- Digoxin - increased digoxin levels
- Repaglinide - increased repaglinide levels, hypoglycemia
- Immunosuppressants (e.g., azathioprine, mycophenolate mofetil) - increased risk of infection and malignancy
Moderate Interactions
- Oral contraceptives (may increase cyclosporine levels)
- Allopurinol (may increase cyclosporine levels)
- Metoclopramide (may increase cyclosporine levels)
- Cimetidine (may increase cyclosporine levels)
- Ranitidine (may increase cyclosporine levels)
- Orlistat (may decrease cyclosporine levels)
- Vaccines (reduced efficacy of vaccines)
Minor Interactions
- Not typically categorized as minor due to narrow therapeutic index and significant interaction potential.
Monitoring
Baseline Monitoring
Rationale: To establish baseline and assess risk of nephrotoxicity.
Timing: Prior to initiation
Rationale: To establish baseline and assess risk of hepatotoxicity.
Timing: Prior to initiation
Rationale: To establish baseline and assess risk of hypertension.
Timing: Prior to initiation
Rationale: To establish baseline and monitor for hematologic abnormalities.
Timing: Prior to initiation
Rationale: To establish baseline and monitor for dyslipidemia.
Timing: Prior to initiation
Rationale: To establish baseline and monitor for electrolyte disturbances.
Timing: Prior to initiation
Rationale: To establish baseline and monitor for hyperuricemia.
Timing: Prior to initiation
Routine Monitoring
Frequency: Initially 2-3 times per week, then weekly, then every 2-4 weeks once stable, or as clinically indicated.
Target: Highly variable based on indication, time post-transplant, and concomitant immunosuppression (e.g., 100-400 ng/mL for transplant, lower for autoimmune).
Action Threshold: Levels outside target range require dose adjustment and re-evaluation.
Frequency: At least twice weekly for first month, then weekly for 2-3 months, then monthly or as clinically indicated.
Target: Stable baseline or within acceptable limits.
Action Threshold: Increase in SCr >30% from baseline on two consecutive measurements requires dose reduction or discontinuation.
Frequency: Weekly for first month, then monthly or as clinically indicated.
Target: Within normal limits.
Action Threshold: Significant elevation requires dose reduction or discontinuation.
Frequency: Daily initially, then weekly, then monthly.
Target: <130/80 mmHg or individualized.
Action Threshold: Sustained hypertension requires antihypertensive therapy or dose adjustment.
Frequency: Monthly or as clinically indicated.
Target: Within normal limits.
Action Threshold: Significant cytopenias require investigation and potential dose adjustment.
Frequency: Monthly or as clinically indicated.
Target: Potassium: 3.5-5.0 mEq/L; Magnesium: 1.5-2.5 mg/dL.
Action Threshold: Hyperkalemia or hypomagnesemia requires intervention.
Frequency: Every 3-6 months.
Target: Within normal limits or target for patient.
Action Threshold: Dyslipidemia requires management.
Symptom Monitoring
- Signs of infection (fever, chills, sore throat, unusual fatigue)
- Signs of kidney dysfunction (decreased urine output, swelling, fatigue)
- Signs of liver dysfunction (yellowing of skin/eyes, dark urine, abdominal pain)
- Headache, tremors, seizures, paresthesias (neurotoxicity)
- Gingival hyperplasia (gum overgrowth)
- Hirsutism (excessive hair growth)
- Gastrointestinal upset (nausea, vomiting, diarrhea)
- Muscle pain or weakness
- Skin changes (new moles, lesions, or changes in existing ones)
Special Patient Groups
Pregnancy
Category C. Cyclosporine crosses the placenta. While data suggest it does not increase the overall risk of major birth defects, there is an increased risk of prematurity and low birth weight. Use only if the potential benefit justifies the potential risk to the fetus.
Trimester-Specific Risks:
Lactation
Cyclosporine is excreted into breast milk. Due to the potential for serious adverse reactions in the breastfed infant (e.g., immunosuppression, nephrotoxicity, malignancy), breastfeeding is not recommended during cyclosporine therapy.
Pediatric Use
Dosing is highly individualized and often requires higher mg/kg doses than adults due to faster drug clearance. Close therapeutic drug monitoring (TDM) is essential. Long-term effects on growth and development, as well as malignancy risk, need careful consideration.
Geriatric Use
No specific dose adjustments based solely on age, but older patients may have reduced renal or hepatic function, requiring dose adjustments and closer monitoring. Increased susceptibility to adverse effects (e.g., nephrotoxicity, hypertension, infections) should be considered.
Clinical Information
Clinical Pearls
- Always specify 'modified' or 'non-modified' cyclosporine when prescribing or discussing, as they are not bioequivalent.
- Therapeutic drug monitoring (TDM) of whole blood trough levels is crucial for safe and effective use.
- Consistency is key: take at the same time daily, and consistently with or without food.
- Educate patients thoroughly on drug interactions, especially grapefruit and St. John's Wort.
- Emphasize the importance of lifelong adherence in transplant patients to prevent rejection.
- Be vigilant for signs of infection, renal dysfunction, and malignancy due to immunosuppression.
- Gingival hyperplasia and hirsutism are common, dose-dependent side effects that can impact patient adherence and quality of life.
Alternative Therapies
- For transplant: Tacrolimus, Sirolimus, Everolimus, Mycophenolate mofetil, Azathioprine, Belatacept.
- For rheumatoid arthritis: Methotrexate, Biologic DMARDs (e.g., TNF inhibitors, IL-6 inhibitors), other conventional DMARDs.
- For psoriasis: Biologic agents (e.g., TNF inhibitors, IL-17 inhibitors, IL-23 inhibitors), Methotrexate, Apremilast, Phototherapy.